KRT8 and nonpapillary renal cell carcinoma: Therefore, our current results suggest that KRT8 may serve as a promising prognostic biomarker with which ccRCC patients can be stratified into distinct risk subgroups to receive appropriate disease-monitoring and guided individualized therapy.